(Q33544398)

27 July 2017

1 reference

title

Atrioventricular nodal ablation and pacemaker implantation in patients with atrial fibrillation (English)

1 reference

27 July 2017

0 references

pacemaker implantation

1 reference

Touboul P

1

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

American Journal of Cardiology

27 July 2017

published in

1 reference

27 July 2017

volume

83

1 reference

27 July 2017

issue

5B

1 reference

27 July 2017

page(s)

241D-245D

1 reference

Epidemiologic features of chronic atrial fibrillation: the Framingham study

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Silent cerebral infarction in chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: Beneficial effect of an added beta adrenergic blocking agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Catheter technique for closed-chest ablation of the atrioventricular conduction system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Late ventricular arrhythmia and sudden death following direct-current catheter ablation of the atrioventricular junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Radiofrequency catheter ablation of the atrioventricular junction from the left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the Working Group on Arrhythmias of the European Societ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

A prospective hemodynamic evaluation of patients with chronic atrial fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Long-term pacemaker dependency after radiofrequency ablation of the atrioventricular junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901036-4

10.1016/S0002-9149(98)01036-4

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference